Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-007918
Filing Date
2025-02-21
Accepted
2025-02-21 17:15:08
Documents
1
Period of Report
2025-02-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4115
  Complete submission text file 0001493152-25-007918.txt   5636
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Issuer) CIK: 0000868278 (see all company filings)

EIN.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 711 STEWART AVE., SUITE 200 GARDEN CITY NY 11530
Business Address
Hollenshead Stuart (Reporting) CIK: 0002057407 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21617 | Film No.: 25653147